The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia

por Kanduri, M, Tobin, G, Åleskog, A, Nilsson, K, Rosenquist, R
Publicado 2011

Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse

por Remes, K, Norrback, K-F, Rosenquist, R, Mehle, C, Lindh, J, Roos, G
Publicado 2000

Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications

por Hultdin, M, Rosenquist, R, Thunberg, U, Tobin, G, Norrback, K-F, Johnson, A, Sundström, C, Roos, G
Publicado 2003

Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia

por Olsson, A, Norberg, M, ökvist, A, Derkow, K, Choudhury, A, Tobin, G, Celsing, F, österborg, A, Rosenquist, R, Jondal, M, Osorio, L M
Publicado 2007

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations

por Rosenquist, R, Ghia, P, Hadzidimitriou, A, Sutton, L-A, Agathangelidis, A, Baliakas, P, Darzentas, N, Giudicelli, V, Lefranc, M-P, Langerak, A W, Belessi, C, Davi, F, Stamatopoulos, K
Publicado 2017

PB2349: LESSONS LEARNED FROM THE MYPAL DIGITAL HEALTH INTERVENTION: CAPITALIZING ON THE PATIENT REPORTED OUTCOMES (PRO) PARADIGM TOWARDS A PARTICIPATORY HEALTHCARE FOR PATIENTS WIT...

por Karamanidou, C., Scarfò, L., Doubek, M., Garani-Papadatos, S., Didi, J., Pontikoglou, C., Kazantzaki, E., Ling, J., Pain, C., Papadaki, H., Rosenquist, R., Stavroyianni, N., Payne, S., Ghia, P., Stamatopoulos, K., Natsiavas, P.
Publicado 2022

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

por Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, C. U., Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P., Pospisilova, S.
Publicado 2018

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

por Sava, G P, Speedy, H E, Di Bernardo, M C, Dyer, M J S, Holroyd, A, Sunter, N J, Marr, H, Mansouri, L, Deaglio, S, Karabon, L, Frydecka, I, Jamroziak, K, Woszczyk, D, Juliusson, G, Smedby, K E, Jayne, S, Majid, A, Wang, Y, Dearden, C, Hall, A G, Mainou-Fowler, T, Jackson, G H, Summerfield, G, Harris, R J, Pettitt, A R, Allsup, D J, Bailey, J R, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Catovsky, D, Allan, J M, Houlston, R S
Publicado 2015

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia

por Parker, H, Rose-Zerilli, M J J, Larrayoz, M, Clifford, R, Edelmann, J, Blakemore, S, Gibson, J, Wang, J, Ljungström, V, Wojdacz, T K, Chaplin, T, Roghanian, A, Davis, Z, Parker, A, Tausch, E, Ntoufa, S, Ramos, S, Robbe, P, Alsolami, R, Steele, A J, Packham, G, Rodríguez-Vicente, A E, Brown, L, McNicholl, F, Forconi, F, Pettitt, A, Hillmen, P, Dyer, M, Cragg, M S, Chelala, C, Oakes, C C, Rosenquist, R, Stamatopoulos, K, Stilgenbauer, S, Knight, S, Schuh, A, Oscier, D G, Strefford, J C
Publicado 2016

P1282: DISEASE-SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MATURE B-CELL NEOPLASMS

por Nadeu, F., Shuai, S., Clot, G., Hilton, L. K., Diaz-Navarro, A., Martín, S., Royo, R., Baumann, T., Kulis, M., López-Oreja, I., Cossio, M., Lu, J., Ljungström, V., Young, E., Plevova, K., Knisbacher, B. A., Lin, Z., Hahn, C. K., Bousquets, P., Alcoceba, M., González, M., Colado, E., Aymerich, M., Terol, M. J., Rivas-Delgado, A., Enjuanes, A., Ruiz-Gaspà, S., Chatzikonstantinou, T., Hägerstrand, D., Jylhä, C., Skaftason, A., Mansouri, L., Stranska, K., Doubek, M., van Gastel-Mol, E. J., Davis, Z., Walewska, R., Scarfò, L., Trentin, L., Visentin, A., Parikh, S. A., Rabe, K. G., Moia, R., Armand, M., Rossi, D., Davi, F., Gaidano, G., Kay, N. E., Shanafelt, T., Ghia, P., Oscier, D., Langerak, A. W., Beà, S., López-Guillermo, A., Neuberg, D., Wu, C. J., Getz, G., Pospisilova, S., Stamatopoulos, K., Rosenquist, R., Huber, W., Zenz, T., Colomer, D., Martín-Subero, J. I., Delgado, J., Morin, R. D., Stein, L. D., Puente, X. S., Campo, E.
Publicado 2022

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

por Jakubowska, A, Rozkrut, D, Antoniou, A, Hamann, U, Scott, R J, McGuffog, L, Healy, S, Sinilnikova, O M, Rennert, G, Lejbkowicz, F, Flugelman, A, Andrulis, I L, Glendon, G, Ozcelik, H, Thomassen, M, Paligo, M, Aretini, P, Kantala, J, Aroer, B, von Wachenfeldt, A, Liljegren, A, Loman, N, Herbst, K, Kristoffersson, U, Rosenquist, R, Karlsson, P, Stenmark-Askmalm, M, Melin, B, Nathanson, K L, Domchek, S M, Byrski, T, Huzarski, T, Gronwald, J, Menkiszak, J, Cybulski, C, Serrano, P, Osorio, A, Cajal, T R, Tsitlaidou, M, Benítez, J, Gilbert, M, Rookus, M, Aalfs, C M, Kluijt, I, Boessenkool-Pape, J L, Meijers-Heijboer, H E J, Oosterwijk, J C, van Asperen, C J, Blok, M J, Nelen, M R, van den Ouweland, A M W, Seynaeve, C, van der Luijt, R B, Devilee, P, Easton, D F, Peock, S, Frost, D, Platte, R, Ellis, S D, Fineberg, E, Evans, D G, Lalloo, F, Eeles, R, Jacobs, C, Adlard, J, Davidson, R, Eccles, D, Cole, T, Cook, J, Godwin, A, Bove, B, Stoppa-Lyonnet, D, Caux-Moncoutier, V, Belotti, M, Tirapo, C, Mazoyer, S, Barjhoux, L, Boutry-Kryza, N, Pujol, P, Coupier, I, Peyrat, J-P, Vennin, P, Muller, D, Fricker, J-P, Venat-Bouvet, L, Johannsson, O Th, Isaacs, C, Schmutzler, R, Wappenschmidt, B, Meindl, A, Arnold, N, Varon-Mateeva, R, Niederacher, D, Sutter, C, Deissler, H, Preisler-Adams, S, Simard, J, Soucy, P, Durocher, F, Chenevix-Trench, G, Beesley, J, Chen, X, Rebbeck, T, Couch, F, Wang, X, Lindor, N, Fredericksen, Z, Pankratz, V S, Peterlongo, P, Bonanni, B, Fortuzzi, S, Peissel, B, Szabo, C, Mai, P L, Loud, J T, Lubinski, J
Publicado 2012